Skip to content

Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report

Drummond E-Wen Mcculloch, Maria Zofia Grzywacz, Martin Bruun Madsen, P.s. Jensen, Brice Ozenne, Sophia Armand, Gitte M. Knudsen, Patrick M. Fisher, Dea Siggaard Stenbæk

Frontiers in Pharmacology March 9, 2022 DOI: 10.3389/fphar.2022.841648 via OpenAlex

Summary

AI-generated from the abstract

Psilocybin, a psychedelic drug, can produce lasting positive psychological changes in healthy people. In 28 healthy volunteers who received 35 medium-high doses, the intensity of the acute mystical experience, measured by the Mystical Experience Questionnaire, predicted positive persisting effects three months later. Specifically, the subscales for positive mood and mysticality were linked to later benefits, while transcendence of time/space and ineffability were not. Qualitative reports described themes of connection with the Universe, familial love, and profound beauty. The type of acute experience appears important for predicting enduring positive outcomes.

Study at a glance

Characteristics Observational cohort Qualitative Peer reviewed
Sample size 28
Population Healthy volunteers
Intervention Psilocybin
Dose medium-high doses
Duration 3-month follow-up
Topics Psilocybin
Keywords Mood Hallucinogen Medicine Clinical psychology
Citations 91
Registration NCT03289949
Key finding The intensity of the acute mystical experience, particularly positive mood and mysticality, predicts positive persisting psychological effects three months after psilocybin administration in healthy volunteers.

Abstract

Psychedelic drugs such as psilocybin have shown substantial promise for the treatment of several psychiatric conditions including mood and addictive disorders. They also have the remarkable property of producing persisting positive psychological changes in healthy volunteers for at least several months. In this study (NCT03289949), 35 medium-high doses of psilocybin were administered to 28 healthy volunteers (12 females). By the end of the dosing day, participants reported the intensity of their acute experience using the 30-item Mystical Experience Questionnaire (MEQ) and an open-form qualitative report from home. Persisting psychological effects attributed to the psilocybin experience were measured using the Persisting Effects Questionnaire (PEQ) 3-months after administration. Using a linear latent-variable model we show that the MEQ total score is positively associated with the later emergence of positive PEQ effects ( p = 3 × 10 −5 ). Moreover, the MEQ subscales “Positive Mood” ( p corr = 4.1 × 10 −4 ) and “Mysticality” ( p corr = 2.0 × 10 −4 ) are associated with positive PEQ whereas the subscales “Transcendence of Time and Space” ( p corr = 0.38) and “Ineffability” ( p corr = 0.45) are not. Using natural language pre-processing, we provide the first qualitative descriptions of the “Complete Mystical Experience” induced by orally administered psilocybin in healthy volunteers, revealing themes such as a sense of connection with the Universe, familial love, and the experience of profound beauty. Combining qualitative and quantitative methods, this paper expands understanding of the acute psilocybin induced experience in healthy volunteers and suggests an importance of the type of experience in predicting lasting positive effects.

Explore topics

Comments

No comments yet.

Log in to comment